Syneos Health, Inc. is a prominent global provider of outsourced biopharmaceutical services, operating with a vast reach across North America, Europe, the Middle East, Africa, the Asia-Pacific region, and Latin America. The company structures its offerings into two principal segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment is dedicated to supporting the complete clinical development journey, from Phase I through IV, for a diverse array of medical innovations including diagnostics, drugs, biologics, devices, and digital therapeutics. Its extensive service portfolio encompasses product development and regulatory consulting, project management, protocol formulation, investigational site selection, clinical monitoring, technology-enabled patient recruitment and engagement strategies, clinical home health support, initiatives promoting clinical trial diversity, biometrics, and regulatory affairs. Conversely, the Commercial Solutions segment focuses on market access and commercialization strategies. Its offerings include deployment solutions, comprehensive communication services (such as public relations, advertising, and medical communications), and expert consulting tailored for the pharmaceutical, biotechnology, and wider healthcare sectors. Established in 2010 and headquartered in Morrisville, North Carolina, the enterprise rebranded as Syneos Health, Inc. in January 2018, having previously operated as INC Research Holdings, Inc.